ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Evofem Biosciences Inc

Evofem Biosciences Inc (EVFM)

0.4782
0.00
(0.00%)
Closed September 19 4:00PM
0.00
0.00
(0.00%)

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
0.4782
Bid
0.465
Ask
0.468
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Market Cap
Previous Close
0.4782
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
-
Shares Outstanding
5,680,000
Dividend Yield
-
PE Ratio
0.11
Earnings Per Share (EPS)
8.8
Revenue
18.22M
Net Profit
50M

About Evofem Biosciences Inc

Evofem Biosciences Inc is a commercial-stage biopharmaceutical company committed to developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health, including hormone-free, woman-controlled contraception and protection from certain sexually transmi... Evofem Biosciences Inc is a commercial-stage biopharmaceutical company committed to developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health, including hormone-free, woman-controlled contraception and protection from certain sexually transmitted infections (STIs). The company's product, Phexxi (lactic acid, citric acid and potassium bitartrate), is a hormone-free, prescription vaginal gel approved in the United States for the prevention of pregnancy. The company is also evaluating its investigational drug candidate EVO100 vaginal gel for the prevention of urogenital transmission of Chlamydia trachomatis infection (chlamydia) and Neisseria gonorrhoeae infection (gonorrhea) in women. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
Headquarters
Wilmington, Delaware, USA
Founded
-

EVFM Latest News

Biopharma Partners with Telemed Firm and Shares are Climbing

This company is striving to change the narratives around women's healthcare and offering solutions that reinforce and improve them. And shares are responding positively to a recent partnership To...

Evofem Biosciences Announces Strong Preliminary Results for the First Quarter of 2023

Evofem Biosciences Announces Strong Preliminary Results for the First Quarter of 2023 PR Newswire SAN DIEGO, June 1, 2023 Increased net product revenue more than 35% in the first quarter of 2023...

Evofem Biosciences Announces 1-for-125 Reverse Stock Split

Evofem Biosciences Announces 1-for-125 Reverse Stock Split PR Newswire SAN DIEGO, May 17, 2023 -- CUSIP number for Evofem will change to 30048L302 on May 18, 2023 -- -- Ticker symbol will change...

Evofem Wins Phexxi Coverage with Largest Payer in New York with No Prior Authorization Required

Evofem Wins Phexxi Coverage with Largest Payer in New York with No Prior Authorization Required PR Newswire SAN DIEGO, April 12, 2023 — Improves Phexxi coverage for more than 5.8 million New York...

Evofem Biosciences Announces Cost Reduction Measures

Evofem Biosciences Announces Cost Reduction Measures PR Newswire SAN DIEGO, March 21, 2023 – Company cuts management pay and lowers headcount to decrease operating costs – – Reductions align with...

Evofem Biosciences Appoints Interim Chief Financial Officer

Evofem Biosciences Appoints Interim Chief Financial Officer PR Newswire SAN DIEGO, March 9, 2023 SAN DIEGO, March 9, 2023 /PRNewswire/ -- Evofem Biosciences, Inc. (OTCQB: EVFM) is pleased to...

Evofem's Phexxi Contraceptive Gel Added to SimpleHealth Product Offering

Evofem's Phexxi Contraceptive Gel Added to SimpleHealth Product Offering PR Newswire SAN DIEGO, Feb. 28, 2023 -- Phexxi is the first and only hormone-free contraceptive offered by reproductive...

Evofem Biosciences Announces FDA Orange Book Listing of Two Additional U.S. Patents for Phexxi

Evofem Biosciences Announces FDA Orange Book Listing of Two Additional U.S. Patents for Phexxi PR Newswire SAN DIEGO, Feb. 27, 2023 -- Evofem now has four Orange Book listed patents covering...

Evofem Biosciences to Explore Strategic Alternatives to Maximize Shareholder Value

Evofem Biosciences to Explore Strategic Alternatives to Maximize Shareholder Value PR Newswire SAN DIEGO, Feb. 23, 2023 SAN DIEGO, Feb. 23, 2023 /PRNewswire/ -- Evofem Biosciences, Inc. (OTCQB:...

Costco Adds Phexxi® to Member Prescription Program

Costco Adds Phexxi® to Member Prescription Program PR Newswire SAN DIEGO, Jan. 10, 2023 SAN DIEGO, Jan. 10, 2023 /PRNewswire/ -- Evofem Biosciences, Inc. (OTCQB: EVFM) today announced that...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
GSIWGarden Stage Ltd
$ 8.17
(259.91%)
70.61M
ZEOZeo Energy Corporation
$ 2.5995
(128.03%)
58.93M
TBIOTelesis Bio Inc
$ 2.9201
(114.71%)
45.9M
NCINeo Concept International Group Holdings Ltd
$ 0.84
(71.43%)
12.66M
VEROVenus Concept Inc
$ 0.8475
(68.66%)
19.71M
HAOHaoxi Health Technology Ltd
$ 0.83
(-72.33%)
8.28M
PGNYProgyny Inc
$ 16.465
(-32.63%)
19.16M
NUZENuZee Inc
$ 0.6998
(-32.06%)
14.05M
RGFReal Good Food Company Inc
$ 0.308
(-28.37%)
362.64k
ALGSAligos Therapeutics Inc
$ 10.18
(-28.11%)
875.44k
NVDANVIDIA Corporation
$ 117.87
(3.97%)
293.47M
SQQQProShares UltraPro Short QQQ
$ 7.76
(-7.62%)
222.38M
HOLOMicroCloud Hologram Inc
$ 0.2328
(15.08%)
120.04M
MAXNMaxeon Solar Technologies Ltd
$ 0.1034
(13.75%)
104.89M
TSLATesla Inc
$ 243.92
(7.36%)
102.64M

Discussion

View Full Feed
blackhawks blackhawks 3 minutes ago
Because a nude dance of morbidly obese Jardiance users spilled over into the naked elbows ad shoot?
Zorax Zorax 4 minutes ago
That wasn't even your writing in the first sentence. Are you trying now to look like you have some sort of intelligence?
timberwolf7 timberwolf7 4 minutes ago
The LIE the economy is 'good'...

Normally, the FED cuts rates to STIMULATE the economy, raises them to cool it down.
So find it interesting to see the LIES that he cut because things are going 'well'.
When in reality, the chatter has been for some time, the policies o
Top Penny Top Penny 4 minutes ago
Let's put this thing in its proper place, that way when the news hits the wires we can all have iced tea on Pluto!!!
LTNC
StayHumble StayHumble 5 minutes ago
ALJ:wow 4+YearsTimelyFilings🟩Thus StillHere🟩2019

--------------------------------------------V. ORDER------------------------------------------


IT IS ORDERED this administrative proceeding IS DISMIS
DBMM
1vman 1vman 5 minutes ago
*****🅰️🅰️🅰️ UBQUs management continues to ignore its shareholders

Not a stock to invest in imo

ENOUGH SAID
UBQU
delerious1 delerious1 5 minutes ago
always best not to fall in love with a stock....I saw a pattern in the "other one" and bailed out with a tidy profit,,,still have it on my Streamer tho
RONN
jour_trader jour_trader 6 minutes ago
Absolutely. Vyvanse may get delayed. OxyContin may get kicked down road for several years. We do know for certain what will be launching over next several months - that alone is a huge win. We haven’t seen any new positive BE trial for a while - lots of R&D being spent. Would love to see a couple in
ELTP
Steady_T Steady_T 6 minutes ago
That is just silly. Even conditional approval gets NWBO a revenue stream. It would not impact EDEN development or the increase is treatment utilization that comes with EDEN.

No way on God's green earth that NWBO "test all time lows...".

Nice try but no cigar.
NWBO
StayHumble StayHumble 6 minutes ago
This SEC Stock Hoax is shot 🚩🚩🚩

DJT
cojoboy cojoboy 7 minutes ago
Would like to see .01 print tomorrow over there..
RONN
1vman 1vman 7 minutes ago
*****🅰️🅰️🅰️ HCMC shareholders stuck with massive losses here thanks to the companies recent split

ENOUGH SAID
HCMC
Yo-Yo Yo-Yo 7 minutes ago
You too v!!! Enjoy your evening!!!!
jammy32 jammy32 7 minutes ago
Great call.
ELTP
Zorax Zorax 7 minutes ago
The nude beach dance commercial showing mostly naked elbows I guess didn't make the censor cut.
StayHumble StayHumble 8 minutes ago
w0w🟩Corporate$UBQU"NO R/S +MERGER AQUISITION" 🟩ohBoy Yowza!
https://x.com/CorporateUbqu/status/1765510100628726105?s=20
https://cdn.vox-cdn.com/uploads/chorus_asset/file/8687957/tenor.gif
UBQU
delerious1 delerious1 8 minutes ago
I think he has an ulterior motive for posting here
HIRU
Alpha14 Alpha14 8 minutes ago
Why no news on the RNVA end...me no like ...
RNVA
Paulie Cashews Paulie Cashews 8 minutes ago
You may be having a reasonable reaction to a never-ending barrage of bad news which you can do very little about.

adserv.stocksite.com/images/paulie/ihsurvey.jpg

www.investorshub.com/boards/board.asp?board_id=2581 Paulie's Pixel Palace
jobynimble jobynimble 9 minutes ago
Kinda wish they just file unaudited and do the typical otc p&d. Get some decent exit liquidity for everyone at least.

That would mean others who bought so you could sell would wind up stuckholders…

That would be okay with you?
BOPO
1vman 1vman 9 minutes ago
*****🅰️🅰️🅰️ DBMM A basement dweller investment , like holding the bag and lose money this is the investment to make --- Wh👀ps !



ENOUGH SAID
DBMM
I-Glow I-Glow 9 minutes ago
Baez doesn't have a business footprint - most of the information about Baez is from the Park created press releases and posts on Twitter (X).

The Bloxcross website doesn't provide an address or phone number - that is very odd.

Who is using Bloxcross payment system.
SPZI
arachnodude arachnodude 9 minutes ago
From the next paragraph, EOT, KBLB elaborates:

Management has undertaken steps as part of a plan to improve operations with the goal of sustaining our operations for the next twelve months and beyond. These steps include (a) raising additional capital and/or obtaining financing; (b) c
KBLB
Jbuffett Jbuffett 10 minutes ago
I can't believe the same folks are still hanging in to titan. If you haven't sold out... It's over... Time to move on to another company. Check out Monogram robotics. Ortho robotics is where the market is heading...
TMDIF
crazy horse 0 crazy horse 0 10 minutes ago
JD Vance: The Immigration Crisis, How Polls Are Used to Fool You, and the Left’s Plan to Stop Trump

https://tuckercarlson.com/jd-vance-interview?utm_campaign=20240918_sept18dailybriefnonsubs&utm_medium=email&utm_source=iterable&utm_content=jdvance

Your Recent History

Delayed Upgrade Clock